Humatica’s new whitepaper on Buy & Build. Download now

closeicon

Humatica’s new whitepaper on Buy & Build. Download now

closeicon

Assessing Organizational Readiness Pre-deal: Deal Makers Need More Than 10 Questions

ndetails

A side-effect of full-priced markets and the industrialisation of private equity is funds looking to upgrade and standardize their deal processes – the way they invest and manage portfolio assets over the life cycle. We see this trend every day across all segments of the market. Funds are developing toolkits and networks of preferred service providers for specific value creation levers – from deal sourcing through exit. In the struggle to differentiate and get a competitive edge, many are doing this in-house. However, even for the biggest players with 50+ companies, this is inefficient and re-inventing the wheel.

In this context, talent, leadership and organizational performance are increasing in relevance as other, simpler value creation levers are already priced in. The ability to get behind the well-rehearsed sales process and understand the true ability of the target to execute is becoming more important as entry multiples grow beyond 10-12x. Understanding organizational readiness is important to anticipate where implementation could stumble or be delayed. It’s no surprise that deal-teams are looking for tools and methods to assess and mitigate organizational risks early-on.

However, it’s a mistake to think there are simple approaches to assess organizations, like there are for pricing and procurement value creation levers. The unique problem with organizations is that there are too many diverse drivers of performance, any one of which can derail the implementation of the best plan. The challenge is that the organization is only as good as its weakest link, and that link could be leadership, org structure, the quality of management processes, culture, competencies, clarity of vision and even systems needed to facilitate efficient collaboration. And, key drivers are context-dependent based on industry and the value creation plan – yet another layer of complexity. Picking the specific organizational levers that make the difference in each case is a new challenge that can’t be mastered with just “10 org questions”.

The right approach is a structured, data-driven methodology that goes both broad, to quickly scan all levers of org performance, and then deep to resolve areas of specific weakness. Rather than strive for best-practice everywhere, identifying and resolving just the highest priority issues in the organization is the right entrepreneurial approach.

Just because it is complex, it doesn’t mean that assessing organizational readiness should be over-simplified or avoided altogether. Humatica’s proven methods, tools and databases have been successfully used by hundreds of buyouts for over 15 years to build organizations that deliver alpha. They have helped countless portfolio company leaders identify and resolve organizational bottlenecks to deliver the full potential plan on time.

This article was originally published as the Humatica Corner in Real Deals magazine. You can access the PDF version here.

Related Insights

The Last Great Arbitrage – Management Process Excellence
30 Sep, 2021 By Humatica

The Last Great Arbitrage – Management Process Excellence

Excess liquidity has flooded private markets and reduced the number of easy targets in private equity. Investors are now competing for ever smaller arbitrage opportunities…

Read more arrowicon
Ignite Your Sales Engine to Turbocharge Growth – An Introduction (1/6)
08 Sep, 2021 By Humatica

Ignite Your Sales Engine to Turbocharge Growth – An Introduction (1/6)

Sales is an essential function of every business. An effective Sales Engine can supercharge the value generated from your products and services. But Sales teams…

Read more arrowicon
Interview with Dr. Thomas Costa of Coventya
28 Jul, 2021 By Humatica

Interview with Dr. Thomas Costa of Coventya

In the new episode of the alpha Talks Podcast, Enno Krey speaks to Dr. Thomas Costa, former CEO of Coventya, a leading international specialty chemicals…

Read more arrowicon

Subscribe to our Monthly Newsletter and other News Updates

Receive our news and valuable perspectives on organizational effectiveness each month.

I agree to Humatica’s Data Protection Policy and that Humatica may use my data to contact me via email.